Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Placental ribonuclease inhibitor (PRI) is a member of a family of proteinaceous cytoplasmic RNase inhibitors that occur in many tissues and bind to both intracellular and extracellular RNases (summarized by Lee et al., 1988 [PubMed 3219362]). Additionally we are shipping RNH1 Kits (31) and RNH1 Proteins (20) and many more products for this protein.
Showing 10 out of 123 products:
Human Monoclonal RNH1 Primary Antibody for EIA, IHC (p) - ABIN400852
Park, Hwang, Kim, Lee, Park, Park, Chung: Functional expression of recombinant human ribonuclease/angiogenin inhibitor in stably transformed Drosophila melanogaster S2 cells. in Cytotechnology 2008
Show all 3 references for 400852
Human Polyclonal RNH1 Primary Antibody for IF, WB - ABIN656371
Martins-de-Souza, Schmitt, Röder, Lebar, Schneider-Axmann, Falkai, Turck: Sex-specific proteome differences in the anterior cingulate cortex of schizophrenia. in Journal of psychiatric research 2010
Show all 2 references for 656371
Cow (Bovine) Polyclonal RNH1 Primary Antibody for WB - ABIN2787412
Johnson, Lavis, Raines: Intraspecies regulation of ribonucleolytic activity. in Biochemistry 2007
Human Polyclonal RNH1 Primary Antibody for FACS, IF (p) - ABIN872914
Tang, Liu, Tian, Xu, Ren, Cui, Fan: Overexpression of ribonuclease inhibitor defines good prognosis and suppresses proliferation and metastasis in human colorectal cancer cells via PI3K/AKT pathway. in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2014
Data suggest that ribonuclease inhibitor (RNH1) protects HeLa cells from ribonuclease 1 (RNase 1 (show RNASE1 Antibodies)).
a novel mechanism of ANG (show ANG Antibodies) in regulating PI3K (show PIK3CA Antibodies)/AKT (show AKT1 Antibodies)/mTOR (show FRAP1 Antibodies) signaling pathway via RI, is reported.
RNH1 bound to RNase 7 (show RNASE7 Antibodies) and suppressed its antimicrobial activity by blocking its ability to bind the cell wall of uropathogenic bacteria.
angiogenin (show ANG Antibodies) and ILK (show ILK Antibodies) signaling pathway plays a pivotal role in mediating the inhibitory effects of RI on melanoma cells growth
RI could play a novel role in inhibiting metastasis of bladder cancer through regulating EMT (show ITK Antibodies) and ILK (show ILK Antibodies) signaling pathways.
RNH1 as a regulator of HDACi resistance in gastric cancer
RI might play a novel role in the development of bladder cancer through regulating EMT (show ITK Antibodies) and the ILK (show ILK Antibodies) signaling pathway.
PTEN (show PTEN Antibodies)-mediated miR (show MLXIP Antibodies)-21 regulation is achieved by inhibiting the interaction between the Drosha (show DROSHA Antibodies) complex and RNH1, revealing previously unidentified role of PTEN (show PTEN Antibodies) in the oncogenic miR (show MLXIP Antibodies)-21 biogenesis
the anti-tumor effect of RNH1 is also involved in suppressing growth and metastasis
RNH1 (as a recombinant fusion protein) is localized to mitochondria, nuclei, and cytosol in HeLa and HCT cells; RNH1 appears to bind to various mitochondrial proteins.
X-ray crystallographic analysis of RNH1 from mouse, bovine and chicken binding to RNase reveals two residues that appear to contribute to the differential binding affinity.
Mouse angiogenin (show ANG Antibodies) inhibitor 1 (show PPP1R1A Antibodies) interacts with hylA of Streptococcus suis.
Cow placenta ribonuclease inhibitor (CPRI) was isolated, characterized and proved to have radical scavenging activities toward different reactive oxygen species.
Placental ribonuclease inhibitor (PRI) is a member of a family of proteinaceous cytoplasmic RNase inhibitors that occur in many tissues and bind to both intracellular and extracellular RNases (summarized by Lee et al., 1988
, ribonuclease/angiogenin inhibitor 1
, placental RNase inhibitor
, placental ribonuclease inhibitor
, RNase inhibitor